A Win For Synthetic Biologics, Inc.
Mon, Feb 07, 2022 at 05:30 PM
Synthetic Biologics, Inc. (SYN:NYSEMKT) shot up at $0.28, a gain of 20%. The stock appeared on our News Catalysts scanner on Wed, Jan 26, 2022 at 04:15 PM in the 'MISCELLANEOUS' category. From Thu, Jan 20, 2022, the stock recorded 20.00% Up Days and 9.09% Green Days
The stock spiked on Fri, Sep 10, 2021 at $0.56 with a volume of 11M+, and its share price has been moving sideways in recent weeks.
About Synthetic Biologics, Inc. (SYN:NYSEMKT)
Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.
Top 10 Gainers:
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 144.62%
- Anghami Inc. (ANGH:NASDAQ), 62.5%
- Origin Agritech Limited (SEED:NASDAQ), 34.53%
- Bakkt Holdings Inc. Class A (BKKT:NYSE), 33.95%
- Luokung Technology Corp. (LKCO:NASDAQ), 24.31%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 23.19%
- Peloton Interactive, Inc. (PTON:NASDAQ), 20.94%
- Castor Maritime Inc. (CTRM:NASDAQ), 20.25%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 19.99%
- ContraFect Corporation (CFRX:NASDAQ), 18.18%